Manipal Health Enterprises Ltd (MANIPALHOS)
π― Key Takeaways
- Revenue grew 7.2% QoQ to βΉ3,091 in Q1FY27.
- Market Cap
- βΉ98,509
- P/B Ratio
- 11.69
- Debt/Equity
- 1.25
- Promoter
- 81.4%
π Quarterly Results (βΉ Cr)
| Metric | Jun 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|
| Revenue | 2,238 | 2,882 | 3,091 |
| Operating Profit | 446 | 506 | 549 |
| OPM % | 19.9% | 17.6% | 17.8% |
| Net Profit | 254 | 187 | 243 |
| EPS | βΉ2.17 | βΉ1.53 | βΉ1.96 |
π¦ Balance Sheet (βΉ Cr)
| Item | Mar 2026 | Mar 2026 |
|---|---|---|
| Equity Capital | 236 | 231 |
| Reserves | 8,190 | 6,188 |
| Borrowings | 10,553 | 11,914 |
| Total Liabilities | 24,865 | 18,737 |
| Fixed Assets | 18,753 | 7,532 |
| Investments | 2,675 | 2,267 |
| Total Assets | 24,865 | 18,737 |
π° Cash Flow Statement (βΉ Cr)
| Item | Mar 2025 |
|---|---|
| Operating | +1,570 |
| Investing | -2,658 |
| Financing | +904 |
| Net Cash Flow | -70 |
π₯ Shareholding Pattern
| Category | Q4FY26 |
|---|---|
| Promoters | 81.4% |
| FII | 0.0% |
| DII | 0.0% |
| Public | 0.0% |
| # Shareholders | 14 |
βοΈ Peer Comparison β Healthcare
| Company | MCap (βΉ Cr) | P/E | ROCE | ROE | D/E |
|---|---|---|---|---|---|
| APOLLOHOSP | 1.25 L Cr | 59.9 | 22.1% | β | 0.60 |
| MANIPALHOS | 98,509 | β | β | β | 1.25 |
| MAXHEALTH | 95,762 | 65.6 | 14.4% | β | 0.27 |
| ASTERDM | 64,094 | 119.0 | 12.9% | β | 0.17 |
| FORTIS | 61,831 | 59.0 | 13.3% | β | 0.29 |
| MEDANTA | 38,059 | 68.4 | 21.9% | β | 0.10 |
| NH | 36,850 | 44.9 | 13.7% | β | 1.07 |
| LALPATHLAB | 32,792 | 47.2 | 29.6% | β | 0.00 |
| KIMS | 32,345 | 151.0 | 9.7% | β | 1.44 |
| POLYMED | 16,633 | 52.8 | 15.1% | β | 0.06 |
π Peer Stock Analyses
π Recent Filings
- π‘ Board Meeting2026-09-29Manipal Health Enterprises held its 16th AGM on September 29, 2026, at 11:00 AM IST via video conferencing from its registered office in Bengaluru. Chβ¦
- π‘ Board Meeting2026-09-29Manipal Health Enterprises held its 16th AGM on September 29, 2026, via video conferencing, confirming quorum and reviewing FY2025-26 results. Chairmaβ¦
- Announcement2026-09-28Manipal Health Enterprises Ltd announced that its trading window will close on October 1, 2026, following SEBI insider trading rules, and will reopen β¦
- π΄ offer document2026-09-18Manipal Health Enterprises redeemed βΉ5,310 crore of non-convertible debentures using IPO proceeds, strengthening its balance sheet and reducing financβ¦
- π‘ buyback redemption2026-09-16Manipal Health Enterprises announced full redemption of Rs. 5,310 crores in non-convertible debentures issued by its subsidiary Manipal Hospitals Privβ¦
- π΄ annual report2026-09-04Manipal Health Enterprises announced its 16th Annual General Meeting on September 29, 2026, and shared the web link to access the Annual Report for FYβ¦
- π΄ annual report2026-09-04Manipal Health Enterprises Ltd convened its 16th AGM on September 29, 2026, to adopt the FY 2025-26 financial statements and approve key governance chβ¦
- π΄ annual report2026-09-04Manipal Health Enterprises Ltd announced its 16th AGM on September 29, 2026, via video conferencing, with e-voting from September 26 to 28. The filingβ¦
- π΄ Announcement2026-08-27Manipal Health Enterprises reported robust Q1 FY27 growth with revenue up 38% YoY to INR 3,091 crores and network EBITDA up 26% YoY to INR 749 crores,β¦
- Announcement2026-08-20Manipal Health Enterprises Limited reported Q1 FY27 results showing 38.1% YoY revenue growth to βΉ3,091 crore and 26.4% YoY EBITDA growth to βΉ749 croreβ¦
Read the full analysis
Quarterly trends, balance sheet, cash flow, peer comparison, and AI insights β sign up free to unlock.
Sign Up Free β Unlock Full Analysis2 free AI queries per day.
Data sourced from stock announcements. Analysis generated by StockFin.ai.
For informational purposes only β not investment advice. Updated 2026-10-01.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
π‘ Get AI alerts when MANIPALHOS files new disclosures
Track MANIPALHOS filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track MANIPALHOS β FreeFree account Β· 2 AI queries/day